相关实验视频

Updated: May 27, 2025

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

激励阿尔茨海默病研究本科生培训 (USTAR):培训下一代老龄化科学家

Robin Casten¹, Megan Kelley², Hakeem Lawal³

¹Department of Psychiatry and Human Behavior, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Journal of the American Geriatrics Society

|February 15, 2025

概括

该USTAR计划培训在阿尔茨海默氏症和相关痴呆症 (ADRD) 研究中代表性不足的少数民族本科生,重点关注健康的社会决定因素. 该倡议旨在增加ADRD研究的多样性,并解决健康差异.

科学领域:

神经科学是一个神经科学.
老年学是指老年学的学科.
公共卫生公共卫生

背景情况:

代表性不足的少数民族 (URM) 的本科生不太可能追求生物医学职业.
少数群体面临着不成比例的阿尔茨海默氏症和相关痴呆症 (ADRD) 负担.
社会文化因素在ADRD中显著影响种族健康差异.

研究的目的:

为URM的本科生提供在ADRD方面的辅导教学,临床和研究经验.
激发对ADRD研究的兴趣,特别关注少数群体健康的社会决定因素 (SDOH).
提高研究技能,促进研究生学习过渡,并评估计划的有效性.

主要方法:

一个为期20个月的跨学科培训计划,为两个由10名URM学生组成的队伍.
强调SDOH和ADRD中的认知功能之间的关系.
托马斯·杰斐逊大学和特拉华州立大学 (一所历史黑人学院和大学) 之间的合作.

主要成果:

该计划旨在增加健康差异研究工作人员的多样性.
参与者将在ADRD研究和护理领域获得丰富的经验.
专注于培养对社会文化对健康的影响的理解.

结论:

USTAR有可能使ADRD的研究人员多样化.
该计划与国家老龄研究所的健康公平使命保持一致.
解决ADRD研究中的差异对于改善所有人群的护理至关重要.

关键词:

痴呆症痴呆症是一种痴呆症.在健康方面存在差异.本科教育学士学位教育.代表性不足的少数民族.

更多相关视频

Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology

Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology

Published on: March 23, 2011

Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans

Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans

Published on: August 15, 2020

相关概念视频

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...